These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 201574)
1. EBV specific secretory IgA in saliva of NPC patients. Presence of secretory piece in epithelial malignant cells. Desgranges C; Li JY; De-Thé Int J Cancer; 1977 Dec; 20(6):881-6. PubMed ID: 201574 [TBL] [Abstract][Full Text] [Related]
2. Presence of Epstein-Barr virus specific IgA in saliva of nasopharyngeal carcinoma patients: their activity, origin and possible clinical value. Desgranges C; de-The G IARC Sci Publ (1971); 1978; (20):459-69. PubMed ID: 215528 [No Abstract] [Full Text] [Related]
3. Neutralizing EBV-specific IgA in throat washings of nasopharyngeal carcinoma (NPC) patients. Desgranges C; De-Thé G; Ho JH; Ellouz R Int J Cancer; 1977 May; 19(5):627-33. PubMed ID: 193801 [TBL] [Abstract][Full Text] [Related]
4. Serum and salivary IgA antibodies against a defined epitope of the Epstein-Barr virus nuclear antigen (EBNA) are elevated in nasopharyngeal carcinoma. Foong YT; Cheng HM; Sam CK; Dillner J; Hinderer W; Prasad U Int J Cancer; 1990 Jun; 45(6):1061-4. PubMed ID: 1693600 [TBL] [Abstract][Full Text] [Related]
5. IgA and nasopharyngeal carcinoma. Desgranges C; De-The G IARC Sci Publ (1971); 1978; (24 Pt 2):883-91. PubMed ID: 221410 [No Abstract] [Full Text] [Related]
6. Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening. Fachiroh J; Paramita DK; Hariwiyanto B; Harijadi A; Dahlia HL; Indrasari SR; Kusumo H; Zeng YS; Schouten T; Mubarika S; Middeldorp JM J Clin Microbiol; 2006 Apr; 44(4):1459-67. PubMed ID: 16597877 [TBL] [Abstract][Full Text] [Related]
7. IgA antibodies to Epstein-Barr viral capsid antigens in saliva of nasopharyngeal carcinoma patients. Ho HC; Ng MH; Kwan HC Br J Cancer; 1977 Jun; 35(6):888-90. PubMed ID: 194619 [No Abstract] [Full Text] [Related]
8. [Determination of S-IgA and free secretory component in saliva]. Seyfarth M; Lange KP; Fröhlich S Allerg Immunol (Leipz); 1986; 32(1):41-6. PubMed ID: 2940849 [TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Henle G; Henle W Int J Cancer; 1976 Jan; 17(1):1-7. PubMed ID: 175020 [TBL] [Abstract][Full Text] [Related]
10. Peculiar secretory IgA system identified in chickens. II. Identification and distribution of free secretory component and immunoglobulins of IgA, IgM, and IgG in chicken external secretions. Watanabe H; Kobayashi K; Isayama Y J Immunol; 1975 Oct; 115(4):998-1001. PubMed ID: 1176771 [TBL] [Abstract][Full Text] [Related]
11. EBV specific antibody-based and DNA-based assays in serologic diagnosis of nasopharyngeal carcinoma. Chan KH; Gu YL; Ng F; Ng PS; Seto WH; Sham JS; Chua D; Wei W; Chen YL; Luk W; Zong YS; Ng MH Int J Cancer; 2003 Jul; 105(5):706-9. PubMed ID: 12740922 [TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr-virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinoma. Ho HC; Ng MH; Kwan HC; Chau JC Br J Cancer; 1976 Dec; 34(6):655-60. PubMed ID: 188437 [TBL] [Abstract][Full Text] [Related]
13. The reliability of IgA antibody to Epstein-Barr virus (EBV) capsid antigen as a test for the diagnosis of nasopharyngeal carcinoma (NPC). Levine PH; Pearson GR; Armstrong M; Bengali Z; Berenberg J; Easton J; Goepfert H; Henle G; Henle W; Heffner D; Huang A; Hyams VJ; Lanier A; Neel HB; Pilch B; Pointek N; Taylor W; Terebelo H; Weiland L Cancer Detect Prev; 1981; 4(1-4):307-12. PubMed ID: 6299561 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of IgA specific antibodies to Epstein-Barr virus capsid and early antigens in nasopharyngeal carcinoma. Puthavathana P; Kositanont U; Chongkolwatana C; Metheetrairut C; Chantarakul N; Nuntarakchaikul S; Wasi C Asian Pac J Allergy Immunol; 1993 Jun; 11(1):39-43. PubMed ID: 8216557 [TBL] [Abstract][Full Text] [Related]
15. Epstein--Barr virus-associated antibodies in IgG and IgA of nasopharyngeal carcinoma patients. Yang CS; Yang HM; Yeh YS; Lynn TC Comp Immunol Microbiol Infect Dis; 1979; 2(2-3):167-75. PubMed ID: 228890 [No Abstract] [Full Text] [Related]
16. Secretory immune response in patients with oropharyngeal carcinoma. Watanabe T; Iglehart JD; Bolognesi DP Ann Otol Rhinol Laryngol; 1983; 92(3 Pt 1):295-9. PubMed ID: 6859748 [TBL] [Abstract][Full Text] [Related]
17. Salivary and serum IgA antibodies to the Epstein-Barr virus glycoprotein gp340: incidence and potential for virus neutralization. Yao QY; Rowe M; Morgan AJ; Sam CK; Prasad U; Dang H; Zeng Y; Rickinson AB Int J Cancer; 1991 Apr; 48(1):45-50. PubMed ID: 1850382 [TBL] [Abstract][Full Text] [Related]
18. Detection of IgG and IgA antibodies to Epstein-Barr virus membrane antigen in sera from patients with nasopharyngeal carcinoma and from normal individuals. Zhu XX; Zeng Y; Wolf H Int J Cancer; 1986 May; 37(5):689-91. PubMed ID: 3009331 [TBL] [Abstract][Full Text] [Related]
19. Serum anti-EBV IgA is inversely related to tumor infiltration by surface IgA positive lymphocytes in nasopharyngeal carcinoma. Gunvén P; Klein G; Henle W; Henle G; Forsby N Biomed Pharmacother; 1983; 37(1):41-4. PubMed ID: 6311307 [TBL] [Abstract][Full Text] [Related]
20. ELISA for the detection of serum and saliva IgA against the BMRFI gene product of Epstein-Barr virus. Nadala EC; Tan TM; Wong HM; Ting RC J Med Virol; 1996 Sep; 50(1):93-6. PubMed ID: 8890046 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]